Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit

SOUTH SAN FRANCISCO, Calif., May 23, 2024 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer and autoimmune...

Related Keywords

Christine Cassiano ,Corporate Affairs Brand Strategy ,Allogene Therapeutics Inc ,Twitter ,Nasdaq ,Annual Oncology Innovation ,South San Francisco ,Forward Looking Statements ,Private Securities Litigation Reform Act ,Quarterly Report ,Allogene Therapeutics ,Investor Contact ,Chief Corporate Affairs ,Brand Strategy ,